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directly assessed on isolated 2 months-old CM stimulated or not with neure-
gulin-1 growth factor. Remarkably, while this treatment resulted in 0.17% of
BrdU uptake in WT CM, it increased up to 9.57 % in KO. KO CM also exhib-
ited significant higher mitotic (pH3+) and cytokinesis (AuroraB+) events
compared to WT. Thus, the capacity for adult KO CM to proliferate is not
restricted to aged CM but more likely an intrinsic potential of young KO CM.
We next assessed the proliferative capacity of 2 month-old KO mice in vivo
using the apectomy model. Remarkably, while WT mice developed a classical
healing process (fibrosis/inflammation), KO mice almost completely regener-
ated the apex as indicated by the presence of mitotic (BrdU+, pH3+,
AuroraB+) CM and significant reduced fibrosis (50%) in the resected zone.
These results demonstrated that ephrin-B1 protein is a specific blocker of
adult CM proliferation and its downregulation represents a huge interest for
future therapeutic approaches in cardiac regenerative medicine.
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The Brain Natriuretic Peptide (BNP) is a cardiac hormone, which promotes
the recovery of cardiac function and the preservation of cardiac tissue in
animal models of heart diseases. Its cardiac protective role in animals was
attributed to fibrosis inhibition, as well as to reduction of cardiomyocyte apop-
tosis and hypertrophy. Recently, we demonstrated that BNP induces heart
regeneration via the stimulation of cardiac precursor cell (CPC) proliferation
and differentiation into mature cardiomyocytes.
The aim of our study was to identify which CPC’s subset is able to respond
to BNP stimulation.
Cardiac precursor cells identified as being Sca-1+ Nkx2.5+ or c-kit+ Nkx2.5+
cells, expressed in neonatal and adult hearts BNP’s receptors (NPR-A and
NPR-B), showing their ability to be activated by BNP treatment. Cell sorting
experiments based on the expression of Sca-1 or c-kit were performed on non-
myocyte cells isolated from neonatal wild-type hearts. Sca-1+ and c-kit+ cells
were cultured up to 3 weeks with or without BNP in differentiating medium.
Sca-1 positive cells, which contained few c-kit+ cells, responded clearly to
BNP stimulation by upregulating mRNA levels of genes coding for Nkx2.5,
Mlc-2v, c-kit, Sca-1, beta and alpha MHC. Furthermore, higher number of
Troponin I+ cells was detected in BNP treated cells compared to untreated
cells, suggesting that Sca-1+ cells differentiated after BNP stimulation into
mature cardiomyocytes. BNP treatment of c-kit+ cells didn’t induce the upreg-
ulation of mRNA coding for cardiomyocyte specific genes. However, we
determined that c-kit positive cells spontaneously differentiated into mature
cardiomyocytes during the 3 weeks of cell culture without BNP stimulation.
To determine which receptor is involved, Sca-1+ cells, isolated from neo-
natal hearts of NPR-A or NPR-B deficient mice, were treated with BNP. The
effects of BNP on wild type and NPR-A KO cells did not differ substantially.
However, Sca-1+ cells isolated from NPR-B deficient hearts couldn’t respond
anymore to BNP stimulation.
Thus, BNP specifically stimulates via NPR-B Sca-1+ cell differentiation
into cardiomyocytes. c-kit+ cells display clearly a cardiogenic potential which
is BNP independent.
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Breakthroughs in stem cell biology and demonstrations of the heart’s endog-
enous regenerative capacities have incited an intense race towards cardiac regen-
eration, i.e. the replacement of lost myocardium after myocardial infarction. In
preclinical trials, cell transplantation therapies, using adult human multipotent
stem cells (e. g, hematopoietic stem cells) into infarcted myocardium has shown
enhanced cardiogenesis in animal models. Nevertheless, results in clinical trials
remain unsatisfactory and determining a suitable cell population that is easily
harvested and improves cardiac repair is challenging.
In previous research, our lab isolated human peripheral blood mononuclear
clones (PBMCs) bearing cardiac mesodermal markers, e.g. c-kit, Islet-1 or
Flk-1. Potentially, these cells can differentiate within the cardiac lineage to
mature cardiomyocytes and participate in heart repair.
We sought to establish an in vitro cardioinstructive differentiation protocol to
derive cardiomyocytes from our PBMC population. For this, we screened three
differentiation protocols, i.e. Keller, Smith and He protocols. To follow cell dif-
ferentiation RT-qPCR and immunostainings were performed for relevant genes,
e.g. Nkx2.5, GATA4, Troponin T (cTNT), β-Myosin heavy chain (β-MHC) and
α-actinin. Results for mRNA expression showed that at least 75% of PBMCs
can derive to a cardiac precursor population (Nkx2.5+/GATA4+) following
Keller and Smith protocol. In Smith protocol, 75% of PBMCs differentiated to
immature cardiomyocytes (cTNT+) of which 50% expressed both cTNT and β-
MHC when co-cultured with neonatal mice ventricular myocytes. Immunofluo-
resence assay showed that PBMCs in both Keller and Smith protocol are
Nkx2.5+/α-actinin+ demonstrating differentiation at the protein level.
Next we evaluated the safety, survival and integration of injected PBMCs
in neonatal Gt(ROSA)26-Tomato mice tissues in vivo. By staining PBMC with
membrane marker PKH2GL, we followed cell homing within the animal tis-
sues visualized by fluorescent microscopy on tissue sections.
In conclusion, we demonstrated that human PBMCs can differentiate,
under certain conditions, into cardiac precursor cells or immature cardio-
myocytes in vitro. These results make them an interesting and promising cell
source for stem cell therapies in cardiac repair.
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Background: Cell therapy using intramyocardial injections of cardiac progen-
itors issued from human embryonic stem cells showed benefits on overloaded
right ventricular (RV) tissue remodelling and arrhythmic susceptibility but this
delivery mode failed to improve RV function. Our aim was to evaluate in a por-
cine model of overloaded RV dysfunction a new delivery mode of such therapy.
Methods: A combined overloaded RV dysfunction was obtained in piglets
using a surgical procedure mimicking repaired tetralogy of Fallot. After
4 months, cell therapy was surgically administrated using 2 types of human
NKX2.5+ cardiac progenitor cell-seeded collagen patches applied on the epi-
cardium: QGel® and pressured-patches. Myocardial function was measured
1 month after transplantation by conductance catheter technique and echocar-
diography (standard and strain). The fate of progenitors was studied using
antibodies directed against Ki67, CD31, actinin and Islet1.
Results: All pigs survived without any complication. Pressured-patches
allowed human progenitors to migrate across the complete myocardium while
QGel® patches restricted the cell migration to only a third of the myocardium.
In both cases, progenitors differentiated toward the cardiac lineage assessed by
Islet1 and actinin expression and maintained their proliferation capacity.
Concerning RV function, only pressured-patches (N=3) tended to improve the
contractility (Emax slope). By contrast, this parameter decreased in QGel®
patches animals (N=2). Moreover, in 2 pressured-patch animals, standard
echocardiographic functional parameters (FAC, TAPSE, s’wave) were main-
tained while 2D strain and strain rate values increased.
Conclusion: Cell therapy using seeded-patches was more conservative for
engrafted cells than intramyocardial injections but only pressured-patches
seemed to give benefits on overloaded RV function and contractility. These
first promising results need to be checked at longer term.
